Clinical and Laboratory Findings in 16 HCV+ Patients With Lymphoplasmacytoid Lymphoma/Immunocytoma
| Patient . | Age/ Sex . | Involved Sites . | Associated Conditions . | HCV Genotype . | Monoclonal Component . | Cryoglobulins (Cryocrit %) . | Rheumatoid Factor (IU/L) . |
|---|---|---|---|---|---|---|---|
| SEL | 63/F | Spleen, BM, LN | LC | 1b | IgMκ | 1 | 45 |
| SEG | 45/M | Spleen, BM, PB | CPH, Type II MC | 1b | IgMκ | 3 | 124 |
| SS | 54/M | BM, PB | CAH, Type II MC, WM, MPGN | 2c | IgMκ | 19 | 6,070 |
| MEL | 34/F | BM | CAH, Type II MC, MPGN | 1b | IgMκ | 3 | 688 |
| HAZ | 68/M | Spleen, BM, LN, PB | LC | 1b | IgMκ | 1 | 57 |
| MS | 67/M | Spleen, BM, LN, PB | WM | 2a | IgMκ | absent | <20 |
| FAV | 50/F | BM | LC, Type II MC | 1b | IgMκ | 4 | 45 |
| LC1 | 47/M | BM | Type II MC, MPGN | 2a | IgMκ | 34 | 1,815 |
| LC2 | 68/F | Spleen, BM, PB | Type II MC | 2a | IgMκ | 2 | 125 |
| LC3 | 77/F | BM, PB | Type II MC, MPGN | nd | IgMκ | 2 | 824 |
| LC4 | 62/M | Spleen, BM, PB | CAH, Type II MC | 1b | IgMκ | 1 | 109 |
| LC5 | 57/F | Spleen, BM, PB | Type II MC, WM | 1b | IgMκ | 15 | 487 |
| LC6 | 66/M | BM | None | 2a | absent | absent | <20 |
| LC7 | 51/M | BM | CAH, Type II MC | 2a | IgMκ | 35 | 200 |
| LC8 | 58/M | BM | Type II MC | 1b | IgMκ | 2 | 600 |
| LC9 | 40/M | Spleen, BM, PB | MPGN | 2a | IgMκ | absent | <20 |
| Patient . | Age/ Sex . | Involved Sites . | Associated Conditions . | HCV Genotype . | Monoclonal Component . | Cryoglobulins (Cryocrit %) . | Rheumatoid Factor (IU/L) . |
|---|---|---|---|---|---|---|---|
| SEL | 63/F | Spleen, BM, LN | LC | 1b | IgMκ | 1 | 45 |
| SEG | 45/M | Spleen, BM, PB | CPH, Type II MC | 1b | IgMκ | 3 | 124 |
| SS | 54/M | BM, PB | CAH, Type II MC, WM, MPGN | 2c | IgMκ | 19 | 6,070 |
| MEL | 34/F | BM | CAH, Type II MC, MPGN | 1b | IgMκ | 3 | 688 |
| HAZ | 68/M | Spleen, BM, LN, PB | LC | 1b | IgMκ | 1 | 57 |
| MS | 67/M | Spleen, BM, LN, PB | WM | 2a | IgMκ | absent | <20 |
| FAV | 50/F | BM | LC, Type II MC | 1b | IgMκ | 4 | 45 |
| LC1 | 47/M | BM | Type II MC, MPGN | 2a | IgMκ | 34 | 1,815 |
| LC2 | 68/F | Spleen, BM, PB | Type II MC | 2a | IgMκ | 2 | 125 |
| LC3 | 77/F | BM, PB | Type II MC, MPGN | nd | IgMκ | 2 | 824 |
| LC4 | 62/M | Spleen, BM, PB | CAH, Type II MC | 1b | IgMκ | 1 | 109 |
| LC5 | 57/F | Spleen, BM, PB | Type II MC, WM | 1b | IgMκ | 15 | 487 |
| LC6 | 66/M | BM | None | 2a | absent | absent | <20 |
| LC7 | 51/M | BM | CAH, Type II MC | 2a | IgMκ | 35 | 200 |
| LC8 | 58/M | BM | Type II MC | 1b | IgMκ | 2 | 600 |
| LC9 | 40/M | Spleen, BM, PB | MPGN | 2a | IgMκ | absent | <20 |
Abbreviations: LC, liver cirrhosis; CAH, chronic active hepatitis; CPH, chronic persistent hepatitis; Type II MC, type II mixed cryoglobulinemia; MPGN, membranoproliferative glomerulonephritis; WM, Waldenstrom's macroglobulinemia; nd, not determined.